Obstructive sleep apnea (OSA) is a prevalent sleep disorder affecting a significant portion of the population, estimated to impact at least 2% to 4% of adults [^1^]. Individuals with OSA experience repeated episodes of airway obstruction during sleep, categorized as hypopneas (partial blockage) and apneas (complete blockage). These events can lead to disruptive symptoms such as loud snoring, gasping for air, choking sensations, and excessive daytime sleepiness. If you’ve been recently diagnosed with sleep apnea or undergone a sleep study, you may have encountered the term AHI in your results. AHI, or Apnea-Hypopnea Index [^2^], is a crucial metric utilized by healthcare professionals to diagnose obstructive sleep apnea (OSA) and determine its severity. This index is fundamental in guiding diagnosis and treatment strategies for sleep apnea.
Decoding the Apnea-Hypopnea Index (AHI)
The Apnea-Hypopnea Index (AHI) serves as a critical diagnostic tool in identifying and classifying the severity of obstructive sleep apnea (OSA). OSA is characterized by the repeated collapse of the upper airway during sleep. When this collapse causes breathing to cease entirely or reduce to a mere 10% of normal airflow [^3^] for a minimum of 10 seconds, it is classified as an apnea. Hypopneas, on the other hand, occur when the airway is partially obstructed, resulting in shallow and restricted breathing. A hypopnea is typically defined as a decrease in airflow of 30% or more for at least 10 seconds. Both apneas and hypopneas disrupt the natural sleep cycle and cause a decrease in blood oxygen levels, which can contribute to serious long-term health complications [^4^].
It is important to distinguish AHI from the central apnea-central hypopnea index (CAHI), which is used for diagnosing central sleep apnea. Central sleep apnea is a different condition where the brain fails to send the correct signals to the respiratory muscles to initiate breathing. AHI specifically focuses on obstructive events, which are the hallmark of OSA.
Measuring Your AHI: The Sleep Study
The apnea-hypopnea index (AHI) is calculated as the average number of apneas and hypopneas experienced per hour of sleep. To determine your AHI score, healthcare providers divide the total count of apnea and hypopnea events [^5^] by the total hours of sleep recorded during a sleep study. For an event to be counted towards the AHI, it must last for at least 10 seconds.
AHI is typically measured during a comprehensive sleep study, also known as polysomnography. This study monitors various physiological parameters while you sleep, including brain waves, blood oxygen saturation, heart rate, and breathing patterns. Polysomnography is usually conducted in a specialized sleep laboratory. However, for some individuals, a simplified version of a sleep study can be performed at home [^6^].
While AHI is the primary metric for diagnosing OSA, doctors may also consider other factors to gain a more complete understanding of the condition’s severity. For example, the oxygen desaturation index (ODI) [^7^] is another valuable measurement. ODI quantifies how often per hour your blood oxygen levels drop below a baseline level for at least 10 seconds. Carbon dioxide levels in the blood are also an important consideration, particularly for children. Elevated carbon dioxide may indicate prolonged periods of reduced breathing, even if there isn’t a complete airway blockage.
Person stretching in bed
AHI Levels: Understanding Severity in Adults and Children
The AHI score is interpreted using a numerical scale, and the ranges differ slightly for adults and children, reflecting physiological differences. In adults, AHI scores are categorized into severity levels of OSA:
- Mild OSA: An AHI score ranging from 5 to 14.9 events per hour.
- Moderate OSA: An AHI score ranging from 15 to 29.9 events per hour.
- Severe OSA: An AHI score of 30 or more events per hour.
In contrast to adults, a lower threshold is used for diagnosing OSA in children. An AHI of 1 or more events per hour can be sufficient for a diagnosis of obstructive sleep apnea in children. Children have a faster respiratory rate compared to adults [^8^] due to their higher metabolism and smaller lung capacity. Consequently, even a single apneic event can have a more significant impact on a child’s health.
While the categorization isn’t as standardized for children as it is for adults, sleep experts generally classify childhood sleep apnea [^9^] into these severity levels:
- Mild Pediatric OSA: AHI of 1 to 5 events per hour.
- Moderate Pediatric OSA: AHI of 6 to 10 events per hour.
- Severe Pediatric OSA: AHI greater than 10 events per hour.
For adolescents, either the adult or pediatric AHI scale may be used for diagnosis, depending on individual factors and clinical judgment.
Sleep Apnea AHI Chart: Adult vs. Pediatric
| OSA Severity | Adult AHI (events/hour) | Pediatric AHI (events/hour) |
|---|---|---|
| Mild OSA | ≥ 5 to < 15 | ≥ 1 to ≤ 5 |
| Moderate OSA | ≥ 15 to < 30 | > 5 to ≤ 10 |
| Severe OSA | ≥ 30 | > 10 |
Limitations of the AHI in Sleep Apnea Diagnosis
While AHI is a valuable tool for diagnosing OSA [^10^], it is crucial to recognize its limitations. AHI alone doesn’t capture the complete picture of sleep apnea severity or its overall impact on an individual’s health.
Variability in Hypopnea Measurement
A key limitation arises from the subjective nature of hypopnea definition. While the definition of apnea, involving a 90% or greater reduction in airflow, is generally consistent, hypopnea definitions are less standardized. Hypopneas, representing partial airway collapses, are more challenging to quantify objectively. Various criteria have been explored for defining hypopneas, often involving a percentage decrease in airflow combined with associated changes in blood oxygen levels or arousals from sleep. However, the lack of a universally accepted definition for hypopnea can lead to variations in AHI scores depending on the criteria used in different sleep labs or studies.
AHI: Focus on Event Frequency, Not Event Impact
The AHI primarily measures the frequency of breathing pauses during sleep. It does not provide information on other critical aspects of these respiratory events that could indicate the severity of OSA. For instance, AHI doesn’t directly reveal the extent to which these breathing pauses affect blood oxygen levels. Repeated drops in blood oxygen over time are a significant concern as they can increase the risk of serious health conditions such as hypertension and diabetes.
Furthermore, AHI only registers that an apnea or hypopnea lasts for at least 10 seconds. It doesn’t differentiate between events of varying durations. Individuals experiencing longer apneas, such as those lasting 30 seconds or more, may face greater health consequences compared to those with shorter events, even if their overall AHI scores are similar.
As AHI is an average calculated over the entire night, it may not capture hourly variations in breathing patterns or the influence of sleep position on apneic events. Moreover, a single-night sleep study used for AHI calculation might not accurately represent an individual’s typical AHI if their sleep apnea severity varies from night to night.
Underestimation of AHI in Home Sleep Tests
Home sleep tests [^11^] are becoming increasingly common for sleep apnea screening. However, it’s important to be aware that AHI calculations from home sleep tests can sometimes underestimate the true AHI. This is because home sleep tests typically calculate AHI based on the total recording time, which may include periods when the person is awake in bed, rather than the precise total sleep time measured in a polysomnogram conducted in a sleep lab. This difference in calculation methodology can lead to an underestimation of AHI by approximately 15% in home sleep tests.
These limitations of AHI are important to consider as they can influence treatment decisions. Relying solely on AHI for treatment recommendations might lead healthcare providers to overlook other relevant aspects of a patient’s health history and symptoms. For example, in individuals with a high AHI but minimal daytime sleepiness, standard OSA treatments might be less effective in reducing the risk of hypertension [^12^] or other cardiovascular problems. Researchers are actively investigating how to best integrate other diagnostic criteria, such as daytime sleepiness, blood oxygen levels, and blood pressure, to create a more comprehensive assessment of OSA severity and guide treatment strategies.
Recent studies suggest that home sleep tests may produce particularly misleading AHI results for women [^13^]. In many women, apnea and hypopnea events are more concentrated during the rapid eye movement (REM) stage of sleep. Events occurring during REM sleep have been linked to higher cardiovascular health risks [^14^] compared to events in other sleep stages. While CPAP machines often include “for her” settings to address potential gender-based differences in sleep apnea, most home sleep tests only quantify the total number of apnea and hypopnea events across the night, without specifying the sleep stage during which they occur. This means that women might be at a greater risk of health complications than indicated by their home sleep test results.
CPAP Therapy and its Impact on AHI
Continuous positive airway pressure (CPAP) therapy, which uses a machine to deliver pressurized air through a mask to keep the airway open, is the primary and most effective treatment for obstructive sleep apnea. Research has demonstrated that consistent CPAP use can significantly reduce AHI, with studies showing an average decrease of 73% [^15^]. In individuals with severe OSA who use their CPAP devices for at least six hours per night, AHI levels can often return to the normal range, below 5 events per hour. This highlights the effectiveness of CPAP in managing OSA and reducing the respiratory events measured by AHI.
Still have questions? Ask our community!
Connect with our Sleep Care Community — a dedicated space for sleep health professionals, product experts, and individuals like you. Whether you’re seeking expert advice for insomnia or exploring mattress options, our community provides support and personalized guidance from sleep specialists.
[^1^]: American Academy of Sleep Medicine (AASM)
[^2^]: National Library of Medicine, Biotech Information
[^3^]: National Library of Medicine, Biotech Information
[^4^]: National Heart, Lung, and Blood Institute (NHLBI)
[^5^]: National Library of Medicine, Biotech Information
[^6^]: Simplified version at home
[^7^]: National Library of Medicine, Biotech Information
[^8^]: Sleep respiratory rate
[^9^]: National Library of Medicine, Biotech Information
[^10^]: Diagnose OSA
[^11^]: Home sleep tests
[^12^]: National Library of Medicine, Biotech Information
[^13^]: Sleep Research Society
[^14^]: Scientific American
[^15^]: National Library of Medicine, Biotech Information
